Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04103541 · ClinicalTrials.gov registry record · NA
Epigenetic Impact of a Psychotherapeutic Program in Adolescents With Severe Adverse Experiences
A NA study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT04103541 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 44 participants.
The verdict
NCT04103541, a NA study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
In this project, the investigator proposes to examine the influence of a psychotherapeutic program, designed for adolescents with a history of early adverse environmental and psychosocial experiences, on gene expression in order to find ways to reverse critical molecular mechanisms that associate extreme childhood stress with the development of a series of health problems, with important repercussions at both the individual and social levels.
Interventions
- BEHAVIORAL IP-Colombia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2019-06-01 |
| Est. Completion | 2019-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04103541
The ClinicalTrials.gov registry entry for NCT04103541 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which IP-Colombia is the first listed.
NCT04103541 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04103541 about?
NCT04103541 is a clinical study titled "Epigenetic Impact of a Psychotherapeutic Program in Adolescents With Severe Adverse Experiences". In this project, the investigator proposes to examine the influence of a psychotherapeutic program, designed for adolescents with a history of early adverse environmental and psychosocial experiences, on gene expression in order to find ways to reverse critical molecular mechanisms that associate ex...
What is the current status of trial NCT04103541?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2019-06-01. Estimated completion is 2019-07-01.
What interventions are being tested in trial NCT04103541?
The interventions under investigation include: IP-Colombia (BEHAVIORAL).
Who is sponsoring clinical trial NCT04103541?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.